News Posts List
The Georgia Intellectual Property Alliance officially launched Monday as a nonprofit designed to serve the state by establishing a better model for creating, protecting and enabling intellectual property. GIPA has created a coalition of education institutions, world-leading research labs, innovation-focused organizations, companies ranging from Fortune 500s to startups and other creators to collaborate on the initiative. The organization will focus on accelerating the market launch of ideas that serve the common good, while specializing in protecting IP, including patents, copyrights, trademarks and trade secrets, according to a news release. Gov. Nathan Deal officially proclaimed October 2018 as “Intellectual Property Month,” in recognition of GIPA and the critical importance of IP to the growth and success of the state’s economy.
A medical technology company out of Alpharetta has acquired Tampa-based Regenerative Medicine Solutions LLC, a biomedical services company in an all-stock transaction. Medovex Corp. was formed to acquire and develop a portfolio of medical tech products and services with disruptive characteristics, the statement said. RMS manages Lung Health Institute, which specializes in cellular therapies to treat chronic obstructive pulmonary disease and other chronic lung disorders. Bill Horne, and founder and former CEO of Laser Spine Institute, is Medovex’s new CEO and chairman of the board of directors as of Oct. 9. Jarrett Gorlin resigned as president and CEO, a filing with the U.S. Securities and Exchange Commission said.
New Initiative to Establish Atlanta as the “Center for Global Health” Discussed at Georgia Bio Innovation Summit
There’s an exciting, new initiative underway to make Atlanta a “center for global health” focusing on disease eradication, economic development and disaster response. That was the topic of discussion at the closing panel, “The Future of Life Sciences,” at the Georgia Bio Innovation Summit Oct. 9 at the Cobb Energy Centre. Moderated by KC Decker or Deloitte Consulting, the panel included: Russell Allen, President and CEO, Georgia Research Alliance; Clark Dean, Senior Managing Director, Transwestern; David Hartnett, Chief Economic Development Officer, Metro Atlanta Chamber; and Maria Thacker Goethe, Acting President and CEO, Georgia Bio, and Executive Director, Georgia Global Health Alliance. In May, the Metro Atlanta Chamber, Georgia Global Health Alliance and Deloitte announced the launch of Global Health ATLas a collaborative initiative designed to create a health innovation district in the heart of metro Atlanta. More details are expected in early 2019.
October 15, 2018 | Atlanta, GA - Georgia Bio would like to congratulate the 2018 Anthony Shuker Scientific Poster Award winners. Selected from nearly 60 competitors, the awardees showcased the best and brightest of Georgia’s talent. This year’s competition was sponsored by UCB, Inc. The Georgia Bio Innovation Summit Poster Session is open to representatives from Georgia-based academia, research institutes and industry alike. Competitors represented Georgia’s research universities and companies in a variety of categories including Molecular and Biological Research; Healthcare IT; Nanotechnology; Drug Discovery and Development; Cell Therapy & Tissue Engineering; and Industrial Production. Each year this session impacts students from across Georgia. Brianna Galbreath, Ph.D. of Georgia State University, was about to graduate with a master’s degree in Chemistry, with a concentration in Industrial Biotechnology, when she participated in the 2017 Poster Session. When asked how the poster session impacted her, she stated “Thanks to my experience presenting my research at the poster session, I decided to get my Ph.D. Georgia Bio is a great organization and has been so supportive. Upon completing her graduate degree, Ms. Galbreath thought she was going to ‘hang up her shoes and be done with school.’ After winning the poster award and meeting different companies at the Summit, she decided to continue her education. Today Ms. Galbreath is working on her Ph.D. in Applied and Environmental Microbiology at Georgia State and deciding on her next career move which is likely commercialization of products using microbiology or zoonotic infectious disease.
Biotech start-up RWDC closes US$13 million Series A2 led by Vickers Venture and WI Harper to produce plastic alternative
Accelerating development of its PHA biodegradable biopolymers to replace single-use plastics SINGAPORE, Oct. 10, 2018 /PRNewswire/ -- Singapore-headquartered biotech start-up RWDC Industries Pte Ltd announced today that it has successfully closed a US$13 million Series A2 round co-led by venture capital firms Vickers Venture Partners and WI Harper Group. Finance firm Ridgevale Enterprises Limited and individual investors also participated in the round. Vickers Chairman and co-founding partner Dr. Finian Tan, along with WI Harper Chairman Mr. Peter Liu, have joined RWDC's board of directors. RWDC Executive Chairman Mr.Roland Wee said: "I am heartened by the trust that WI Harper, Vickers Venture Partners, Ridgevale Enterprises Limited and all our other investors have shown in us. We are a highly capable, passionate, and experienced team of scientists, engineers, financiers and marketers. This team is determined and confident in realising our vision of helping make this planet a greener place for future generations."
The Georgia Research Alliance’s Michael Cassidy is joining Emory University, according to Emory President Claire E. Sterk. Cassidy will take a new position that is designed to provide vision and leadership to promote biomedical innovation and enhance the university’s economic engagement in the Atlanta region and beyond. As director of the new Emory Biomedical Catalyst, Cassidy will lead efforts to enhance innovation, entrepreneurship and development of intellectual property, as well as identifying and developing areas of frontier research. He began working with Emory this week. “Emory University’s research initiatives have benefitted society in many ways,” Sterk said in a release. “Mike Cassidy brings great experience in translating research into impact, and his work here will energize an already vibrant and collaborative faculty and student culture.”
Necessity being the mother of invention, it was only a matter of time before a biodegradable plastic straw—not a poor paper substitute—came on the scene. That’s what Danimer Scientific, a developer and manufacturer of biodegradable plastic products, announced today with the creation of what it calls the first fully biodegradable plastic straw using its Nodax polyhydroxyalkanoate (PHA) material. “The environmental impact of straws and other single-use plastic items has become a critical issue for cities and companies across the country,” said Scott Tuten, Chief Marketing Officer at Danimer Scientific. “The challenge is that there are few durable, yet eco-friendly alternatives available. Thankfully, research has found that PHA effectively biodegrades in environments ranging from waste treatment facilities to landfills and oceans. With that stamp of approval, we are excited to be bringing truly biodegradable straw resins in the near future to businesses that are looking to replace petrochemical plastic straws in restaurants, amusement parks and more.”
American Cancer Society CEO Gary M. Reedy to discuss organization’s new venture fund to commercialize promising new cancer therapies Centers for Disease Control and Prevention Director Dr. Robert R. Redfield in conversation with Chief Medical Officers from Quest and Abbvie to discuss digital health innovation in the 21stcentury Atlanta, Georgia (October 2, 2018) – Georgia Bio announced today keynote and featured speakers for its Annual Innovation Summit, Tues., Oct. 9, 2018 at Cobb Galleria. Gary M. Reedy, CEO, American Cancer Society (ACS), will discuss the organization’s new venture fund and its plans to commercialize cancer-focused therapies, medical devices and technologies.
Atlanta, GA - (NewMediaWire) - September 26, 2018 - via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines, announced today that the U.S. Department of Defense (DoD) has awarded the Company a $2,442,307 cooperative agreement in supportof its novel Lassa Fever (LF) vaccine development program. The grant was awarded by the U.S. Army Medical Research Acquisition Activity pursuant to the Peer Reviewed Medical Research Program (PRMRP), part of the Congressionally Directed Medical Research Programs (CDMRP). In addition to the grant funds provided directly to GeoVax, DoD will also fund testing of the GeoVax vaccine by U.S. Army scientists under a separate subaward. The project award, entitled “Advanced Preclinical Development and Production of Master Seed Virus of GEO-LM01, a Novel MVA-VLP Vaccine Against Lassa Fever”, will support generation of immunogenicity and efficacy data for GeoVax’s LF vaccine candidate in both rodent and nonhuman primate models, as well as manufacturing process development and cGMP production of vaccine seed stock in preparation for human clinical trials. The work will be performed in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the Geneva Foundation, and Advanced Bioscience Laboratories (ABL).
Atlanta, Georgia (September 26, 2018) – Georgia Bio today announced that Maria Thacker Goethe has assumed the role of Acting President and CEO for the trade association and the Georgia BioEd Institute. She will also remain in her capacity as Executive Director for the Georgia Global Health Alliance. Ms. Thacker Goethe has served in a variety of roles for Georgia Bio over the years including Marketing, Membership and Project Manager. Since 2013, she served as Vice President of Operations. An innovative thinker with broad-based expertise in operations, community relationship building, and marketing Ms. Thacker Goethe has been a driving force behind Georgia Bio’s programs and the development of the Georgia BioEd Institute. As the organization has grown, Ms. Thacker Goethe’s role and responsibilities have continued to increase and evolve. Her institutional knowledge of the organization and the community positions Georgia Bio for continued success.
|Neon CRM by Neon One|